← FDA Drug Approvals (Drugs@FDA)
GADOTERATE MEGLUMINE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: HENGRUI PHARMA · Approved 2022-04-11
Drug application
- FDA Application #
ANDA215304- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- GADOTERATE MEGLUMINE
- Generic name
- GADOTERATE MEGLUMINE
- Active ingredients
- GADOTERATE MEGLUMINE
- Dosage form
- SOLUTION
- Route
- INTRAVENOUS
- Marketing status
- Discontinued
- Sponsor
- HENGRUI PHARMA
- Manufacturer
- Fresenius Kabi USA, LLC
- First approval
- 2022-04-11
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown